PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation.

Azoitei N, Becher A, Steinestel K, Rouhi A, Diepold K, Genze F, Simmet T, Seufferlein T. · 2016

Read PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation. by Azoitei N, Becher A, Steinestel K, Rouhi A, Diepold K, Genze F, Simmet T, Seufferlein T. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4704385.txt.

Description

Ninel Azoitei, Alexander Becher, Konrad Steinestel, and five colleagues studied the enzyme PKM2 in pancreatic cancer, in Molecular Cancer in 2016. PKM2 runs the last step of sugar breakdown and is abundant in cancer cells, where it also wears other hats. The team asked how it helps tumors grow blood vessels, focusing on pancreatic tumors, which often sit in low-oxygen conditions. Lab assays, tumor grafts, and human tissue samples were combined.

The enzyme appeared strongly in sixty-eight percent of human pancreatic tumor samples and nearly all tested cell lines. Removing it slowed cell growth, raised cell death, and shrank grafted tumors with fewer vessels. The mechanism ran through two switches, NF-kappaB and the oxygen sensor HIF-1alpha, which together drive release of the vessel signal VEGF. The study ties a metabolic enzyme to tumor blood supply, naming a possible choke point for therapy.

Catalog record

CREATORAzoitei N, Becher A, Steinestel K, Rouhi A, Diepold K, Genze F, Simmet T, Seufferlein T.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4704385

Browse the full library · About the Tower of Babel